The complaint investigation for a false positive result for one patient when tested with the architect total b-hcg assay included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labelling review, device history record review and field data review for the complaint lot.Trending review determined no adverse trend for the product.Device history record review did not identify any non-conformances or deviations with the likely cause lot.In house testing of panels which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.World wide data from abbottlink was reviewed and determined that patient median result for the lot is comparable with other lots in the field.Based on our investigation, we have determined that there is no general issue with the architect total b-hcg reagent lot identified in the complaint.
|